GlaxoSmithKline Pharmaceuticals Limited

BSE:500660 Stock Report

Market Cap: ₹420.9b

GlaxoSmithKline Pharmaceuticals Management

Management criteria checks 3/4

We currently do not have sufficient information about the CEO.

Key information

Bhushan Akshikar

Chief executive officer

₹67.9m

Total compensation

CEO salary percentage23.51%
CEO tenure3.4yrs
CEO ownershipn/a
Management average tenure1.6yrs
Board average tenure4yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Bhushan Akshikar's remuneration changed compared to GlaxoSmithKline Pharmaceuticals's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2025n/an/a

₹10b

Sep 30 2025n/an/a

₹10b

Jun 30 2025n/an/a

₹10b

Mar 31 2025₹68m₹16m

₹9b

Dec 31 2024n/an/a

₹9b

Sep 30 2024n/an/a

₹7b

Jun 30 2024n/an/a

₹6b

Mar 31 2024₹67m₹15m

₹6b

Dec 31 2023n/an/a

₹5b

Sep 30 2023n/an/a

₹6b

Jun 30 2023n/an/a

₹6b

Mar 31 2023₹34m₹4m

₹6b

Compensation vs Market: Bhushan's total compensation ($USD719.58K) is about average for companies of similar size in the Indian market ($USD720.76K).

Compensation vs Earnings: Bhushan's compensation has been consistent with company performance over the past year.

CEO

Bhushan Akshikar

3.4yrs
Tenure
₹67,949,000
Compensation

Mr. Bhushan Akshikar is Managing Director of GlaxoSmithKline Pharmaceuticals Limited from December 1, 2022. He served as Additional Director of GlaxoSmithKline Pharmaceuticals Limited since March 18, 2021...

Leadership Team

NamePositionTenureCompensationOwnership
Bhushan Akshikar
MD & Executive Director3.4yrs₹67.95mno data
Ronojit Biswas
CFO & Whole-Time Directorless than a yearno datano data
Aparajita Rajput
Vice President of Technology2.3yrsno datano data
Ajay Nadkarni
VP of Administration & Real Estate and Company Secretaryno data₹11.57mno data
Amit Pandey
Executive Vice President of Legal4.3yrsno datano data
Simrat Sohal
Vice President of Ethics & Compliance3.3yrsno datano data
Carson Dalton
Executive Vice President of Communications & Government Affairs1.2yrsno datano data
Harsh Trehan
Executive Vice President of Human Resourcesless than a yearno datano data
Sukanya Choudhary
Executive Vice President of Regulatory Affairsno datano datano data
Shalini Menon
Executive Vice President of Medical Affairs1.8yrsno datano data
Rishikesh Jaiwant
Executive Vice President of Supply Chain Operations1.3yrsno datano data
Vishwanath Swarup
Executive VP of General Medicines & Commercial Head of General Medicinesless than a yearno datano data
1.6yrs
Average Tenure

Experienced Management: 500660's management team is not considered experienced ( 1.6 years average tenure), which suggests a new team.

Board Members

NamePositionTenureCompensationOwnership
Bhushan Akshikar
MD & Executive Directorno data₹67.95mno data
Ronojit Biswas
CFO & Whole-Time Directorless than a yearno datano data
Renu Karnad
Non-Executive Chairperson7.1yrs₹3.30m0.00035%
₹ 1.5m
Manu Anand
Independent Director4yrs₹2.65mno data
Subesh Williams
Non Executive Director9.1yrsno datano data
Anup Wadhawan
Independent Director1.2yrs₹33.00kno data
Somasundaram Palamadairamaswamy
Independent Director1.2yrs₹33.00kno data
Sunita Maheshwari
Non-Executive & Independent Director6yrs₹2.40mno data
4.0yrs
Average Tenure
64.5yo
Average Age

Experienced Board: 500660's board of directors are considered experienced (4 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/05/09 23:29
End of Day Share Price 2026/05/08 00:00
Earnings2025/12/31
Annual Earnings2025/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

GlaxoSmithKline Pharmaceuticals Limited is covered by 21 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
null null360 ONE Capital Market Private Limited
Rohit Bhat360 ONE Capital Market Private Limited
Shirish PardeshiAnand Rathi Shares and Stock Brokers Limited